US Homeopathic Firm’s Failure To Test Supplies, Lax Approach On Recalls Lead To Warning

Although Washington Homeopathic informed FDA it recalled homeopathics manufactured by a supplier on import alert and would recall “high risk” tinctures, it would allow its customers to decide whether to return other products also identified as potentially adulterated.

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration

More from Recalls

More from Policy & Regulation